The role of systemic corticosteroid therapy in erythema multiforme major and stevens-johnson syndrome: a review of past and current opinions.
作者信息
Michaels Brent
机构信息
Brent Michaels, DO, is Dermatology Resident at Valley Hospital Medical Center, Touro University College of Osteopathic Medicine, Las Vegas, Nevada.
出版信息
J Clin Aesthet Dermatol. 2009 Mar;2(3):51-5.
Abstract
摘要
相似文献
1
The role of systemic corticosteroid therapy in erythema multiforme major and stevens-johnson syndrome: a review of past and current opinions.
J Clin Aesthet Dermatol. 2009 Mar;2(3):51-5.
2
Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Ophthalmology. 1995 Nov;102(11):1669-76. doi: 10.1016/s0161-6420(95)30811-1.
3
Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019.
4
Target lesions on the lips: childhood herpes simplex associated with erythema multiforme mimics Stevens-Johnson syndrome.
J Am Acad Dermatol. 1997 Nov;37(5 Pt 2):848-50. doi: 10.1016/s0190-9622(97)80009-6.
5
[Erythema multiforme in children versus Stevens-Johnson syndrome].
Wiad Lek. 2000;53(1-2):43-8.
6
Head and neck manifestations of erythema multiforme in children.
Otolaryngol Head Neck Surg. 1994 Sep;111(3 Pt 1):236-42. doi: 10.1177/01945998941113P112.
7
Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
J Dermatol. 1997 Nov;24(11):726-9. doi: 10.1111/j.1346-8138.1997.tb02524.x.
8
Mycoplasma pneumoniae-associated Stevens-Johnson syndrome exhibits lymphopenia and redistribution of CD4+ T cells.
J Formos Med Assoc. 2003 Jan;102(1):55-8.
9
Erythema multiforme due to Mycoplasma pneumoniae infection in two children.
Pediatr Dermatol. 2006 Nov-Dec;23(6):546-55. doi: 10.1111/j.1525-1470.2006.00307.x.
10
Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review.
J Am Acad Dermatol. 2015 Feb;72(2):239-45. doi: 10.1016/j.jaad.2014.06.026.
引用本文的文献
1
Mycoplasma-Induced Rash and Mucositis: Ocular Manifestations, Treatment and Outcomes in a Paediatric Population.
J Paediatr Child Health. 2025 Aug;61(8):1263-1269. doi: 10.1111/jpc.70103. Epub 2025 Jun 5.
2
Atypical Stevens-Johnson Syndrome in a Patient With Mycoplasma pneumoniae Infection: A Case Report.
Cureus. 2024 Oct 2;16(10):e70669. doi: 10.7759/cureus.70669. eCollection 2024 Oct.
3
Oral Erythema Multiforme: A Case Report and Review of Diagnostic, Therapeutic and Prognostic Challenges.
Cureus. 2024 Aug 13;16(8):e66749. doi: 10.7759/cureus.66749. eCollection 2024 Aug.
4
From tumor to tolerance: A comprehensive review of immune checkpoint inhibitors and immune-related adverse events.
Asia Pac Allergy. 2024 Aug;14(3):124-138. doi: 10.5415/apallergy.0000000000000146. Epub 2024 May 30.
5
Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions.
Cureus. 2024 Jul 16;16(7):e64654. doi: 10.7759/cureus.64654. eCollection 2024 Jul.
6
Successful treatment of erythema multiforme major with cyclosporine in a paediatric patient.
Postepy Dermatol Alergol. 2024 Jun;41(3):331-334. doi: 10.5114/ada.2024.141162. Epub 2024 Jun 30.
7
Exploring the association between erythema multiforme and HIV infection: some mechanisms and implications.
AIDS Res Ther. 2024 Apr 18;21(1):24. doi: 10.1186/s12981-024-00607-6.
8
Efficacy/Safety of the Use of Glucocorticoids in Oral and Maxillofacial Surgery.
Dent J (Basel). 2023 Oct 17;11(10):239. doi: 10.3390/dj11100239.
9
Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.
SAGE Open Med Case Rep. 2022 Aug 17;10:2050313X221117887. doi: 10.1177/2050313X221117887. eCollection 2022.
10
Erythema multiforme in children.
Can Fam Physician. 2022 Jul;68(7):507-508. doi: 10.46747/cfp.6807507.
本文引用的文献
1
Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
J Am Acad Dermatol. 2008 Jan;58(1):33-40. doi: 10.1016/j.jaad.2007.08.039. Epub 2007 Oct 4.
2
Oral mucosal diseases: erythema multiforme.
Br J Oral Maxillofac Surg. 2008 Mar;46(2):90-5. doi: 10.1016/j.bjoms.2007.07.202. Epub 2007 Sep 4.
3
Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis.
Acta Derm Venereol. 2007;87(2):144-8. doi: 10.2340/00015555-0214.
4
Erythema multiforme.
Am Fam Physician. 2006 Dec 1;74(11):1883-8.
5
Use of steroids for erythema multiforme in children.
Can Fam Physician. 2005 Nov;51(11):1481-3.
6
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
Drug Saf. 2002;25(13):965-72. doi: 10.2165/00002018-200225130-00006.
7
High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme.
Pediatr Dermatol. 2000 Mar-Apr;17(2):87-90. doi: 10.1046/j.1525-1470.2000.01720.x.
8
Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases.
Allergy Asthma Proc. 2000 Mar-Apr;21(2):101-5. doi: 10.2500/108854100778250914.
9
Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children.
Eur J Pediatr. 1997 Feb;156(2):90-3. doi: 10.1007/s004310050561.
Zotero 插件